IBBJ

NASDAQ

Defiance Nasdaq Junior Biotechnology ETF

Sectorn/aIndustryn/aIPOn/a

News1/Ratings0

The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization ("junior") companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a "replication" strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.

Latest news

1 item

1644dPR
Defiance Announces Fund Closure
NEW YORK, Oct. 22, 2021 /PRNewswire/ -- Defiance ETFs announced today that the Board of Trustees of ETF Series Solutions (the "Trust") has determined to close and liquidate the Defiance Nasdaq Junior Biotechnology ETF (NASDAQ:IBBJ) (the "Fund") effective immediately after the close of business on December 3, 2021. Defiance ETFs recommended the liquidation and closure of the Fund after consideration of the Fund's prospects for growth, among other factors. The Fund's last day of trading will be December 2, 2021, which will also be the final day for creation unit orders by authorized participants. The Fund will conclude operations and distribute the remaining proceeds to shareholders promptly a